ClinicalTrials.Veeva

Menu

A Double Blind Randomized Controlled Evaluation of the HBLPADD-coil Transcranial Magnetic Stimulation (TMS) Device - Efficacy and Safety In Subjects With ADHD.

S

Shalvata Mental Health Center

Status

Unknown

Conditions

ADHD

Treatments

Device: HBLPADD coil deep TMS
Device: Sham

Study type

Interventional

Funder types

Other

Identifiers

NCT01723319
SH-0025-12

Details and patient eligibility

About

Objectives:The purpose of the study is to explore the efficacy and safety of HBLPADD Coil deep brain TMS in subjects with ADHD.

Patient Population: The intention is to treat 40 patients diagnosed with ADHD. The patients will be of all racial, ethnic and gender categories, ranging from 18 to 65 years of age.

Structure: The study is a randomized, prospective, 5 weeks, double blind study. Blinding: The treatment administrator and the study personnel and patients will be masked to the treatment being administrated.

The study group will receive active dTMS treatment and the control group will receive an inactive, sham treatment

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients between the ages of 18-65(male and female).
  2. Diagnosed as suffering from Attention-Deficit Hyperactivity Disorder according to the DSM IV.
  3. Patients taking medication for ADHD will give their consent to stop those medication 48 before entering the study and throughout the daily treatments.
  4. Gave informed consent for participation in the study.
  5. If referred by the treating psychiatrist, he or she approves of the subjects participation in the study.

Exclusion criteria

  1. Suffering from other diagnosis on axis 1.
  2. antipsychotic treatment with stabilizers; medications from the Benzodiazepines group are allowed, if need be,to a maximum dosage of 2 mg lorazepam.
  3. History of lack of tolerance to TMS.
  4. Axis 2 diagnosis according to the DSM IV.
  5. Substantial suicidal risk as judged by the treating psychiatrist or by an independent psychiatrist.
  6. Attempted suicide in the past year.
  7. High and not controlled blood pressure.
  8. History of epilepsy, seizure, or hot spasm.
  9. History of epilepsy or seizure in first degree relatives.
  10. History of a significant head injury
  11. History of metal in the head (outside the mouth space).
  12. Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, surgical clips or any medical pumps.
  13. Use of hearing aids for hearing loss.
  14. History of frequent or severe headaches.
  15. History of drug or alcohol abuse during the last year.
  16. Inability to achieve satisfying level of communication with the subject.
  17. Participation in current clinical study or clinical study within 30 days prior to this study
  18. Patients declared as legally incompetent, with an appointed physical guardian and/or cannot sign informed consent due to cognitive incompetence.
  19. Women - Pregnancy or not using a reliable method of birth control.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups

1
Experimental group
Description:
deep TMS treatment
Treatment:
Device: HBLPADD coil deep TMS
2
Sham Comparator group
Description:
inactive treatment
Treatment:
Device: Sham

Trial contacts and locations

1

Loading...

Central trial contact

Yechiel Levkovitz, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems